Bronchoscopic interventions for severe emphysema: Where are we now?
Pallav L ShahDirk-Jan SlebosPublished in: Respirology (Carlton, Vic.) (2020)
Patients with severe emphysema have limited treatment options and only derive a small benefit from optimal medical treatment. The only other therapy to have significant clinical beneficial effect in emphysema is LVRS but the perceived risk and invasiveness of surgery has fuelled bronchoscopic approaches to induce lung volume reduction. There are multiple bronchoscopic methods for achieving volume reduction in severe emphysema: EBV, airway bypass procedure, endobronchial coils, thermal (vapour) sclerosis and chemical sclerosis (sealants). Optimal patient selection is key to successful patient outcomes. This review discusses bronchoscopic approaches for emphysema treatment which has progressed through clinical trials to clinical practice.
Keyphrases
- chronic obstructive pulmonary disease
- lung function
- pulmonary fibrosis
- idiopathic pulmonary fibrosis
- clinical trial
- minimally invasive
- clinical practice
- early onset
- healthcare
- depressive symptoms
- social support
- mental health
- case report
- randomized controlled trial
- cystic fibrosis
- bone marrow
- air pollution
- coronary artery bypass
- ultrasound guided
- drug induced
- combination therapy
- atrial fibrillation
- acute coronary syndrome
- replacement therapy
- cell therapy
- smoking cessation
- fine needle aspiration
- open label